Cargando…
Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
BACKGROUND: Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD) is most classically associated in both children and adults with phenotypes including bilateral and recurrent optic neuritis (ON) and transverse myelitis (TM), with the absence of brain lesions characteristic of multi...
Autores principales: | Seneviratne, Sinali O., Marriott, Mark, Ramanathan, Sudarshini, Yeh, Wei, Brilot-Turville, Fabienne, Butzkueven, Helmut, Monif, Mastura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905766/ https://www.ncbi.nlm.nih.gov/pubmed/35264149 http://dx.doi.org/10.1186/s12883-022-02612-6 |
Ejemplares similares
-
Cerebellar Ataxia Followed by Stiff Person Syndrome in a Patient with Anti-GAD Antibodies
por: Seneviratne, Sinali O., et al.
Publicado: (2020) -
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016) -
Overlapping central and peripheral nervous system syndromes in MOG
antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020) -
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014) -
International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)